Overview

Cardiovascular System in Obesity: Effect of Treatment

Status:
Completed
Trial end date:
1988-04-01
Target enrollment:
Participant gender:
Summary
To determine the long-term efficacy of the combination therapy of phentermine and fenfluramine in conjunction with diet, exercise, and behavior modification in the treatment of simple, moderate obesity.
Phase:
Phase 2
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Fenfluramine
Phentermine